3rd Quarter - Report

BROWN RUDNICK LLP for APOTEX CORPORATION

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

H.R. 2212 & S. 974, the Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act. S. 2476-Expanding Access to Low Cost Generic Drugs Act; Issues relating to generic drug pricing.

LobbyistCovered position, as disclosed
HENRY W MENN CoS, Sen. Bob Graham (01 - 04); Min SD & Counsel, Cmte on Vet Affairs (04); Sp Asst Leg Aff, FDA Off of Commission (93-95)

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 2476 (115th), S. 974 (115th), H.R. 2212 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.